Cite
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.
MLA
Wang, Shuai, et al. “FDA-Approved Pyrimidine-Fused Bicyclic Heterocycles for Cancer Therapy: Synthesis and Clinical Application.” European Journal of Medicinal Chemistry, vol. 214, Mar. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2021.113218.
APA
Wang, S., Yuan, X.-H., Wang, S.-Q., Zhao, W., Chen, X.-B., & Yu, B. (2021). FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. European Journal of Medicinal Chemistry, 214, N.PAG. https://doi.org/10.1016/j.ejmech.2021.113218
Chicago
Wang, Shuai, Xiao-Han Yuan, Sai-Qi Wang, Wen Zhao, Xiao-Bing Chen, and Bin Yu. 2021. “FDA-Approved Pyrimidine-Fused Bicyclic Heterocycles for Cancer Therapy: Synthesis and Clinical Application.” European Journal of Medicinal Chemistry 214 (March): N.PAG. doi:10.1016/j.ejmech.2021.113218.